“adimab” Archives

in
Entry Author Date Location
Gerngross Mulls Buying Back GlycoFi After Merck Closes HQ 05/17/16 Boston
East Coast Biotech Roundup: Sarepta, Nico, Ironwood & More 04/28/16 Boston
Nimbus’s LLC Origins Pay off As Gilead Shells Out $400M For Liver Drug 04/04/16 Boston
East Coast Bio Roundup: PCSK9 Battle, NYU Startups, Blueprint & More 03/17/16 Boston
Racing Zika: For Every Short Cut, There’s An Open Question 03/15/16 National
Stealth Co Unveiling, New Speakers Added to Nov. 17 Healthcare Event 11/13/15 Boston
Veterans Day Special Ending For Our Nov. 17 Health Summit: Save $75 11/09/15 Boston
Special Rate Ends Today For Our Nov. 17 Health Summit: Save $100 11/03/15 Boston
Alector Raises $32M For Immune-Based Neuro Drug Development 09/16/15 San Francisco
East Coast Biotech Roundup: PrecisionFDA, Avitide, Foresight & More 08/07/15 Boston
Avitide Gets $7.6M More to Purify Complex Biologics 08/06/15 Boston
East Coast Biotech Roundup: NY Bio, Synageva, Kadmon & More 05/08/15 New York
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test 03/18/15 Boston
NimbleGen Cofounder Opens Invenra, A “Cell-Free” Antibody Shop 11/05/14 Wisconsin
East Coast Biotech Roundup: Gerngross, Akili, Intercept, & More 01/10/14 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Alector Goes After Alzheimer’s, With Cash from Polaris & OrbiMed 10/31/13 San Francisco
East Coast Life Sciences Roundup: Foundation, Ophthotech, Sato, & More 09/27/13 Boston
East Coast Life Sciences Roundup: Mana, Medivizor, Regado, & More 08/23/13 New York
Adimab Teams Up With Celgene, Innovent, in Latest Partnership Deals 08/20/13 Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Adimab Turns Cash Flow Positive With GSK, Biogen Tech Transfer Deals 07/26/13 Boston
Tillman Gerngross’ Plan to Revamp Tech Transfer at Dartmouth 07/24/13 Boston
East Coast Life Sciences Roundup: Optimer, Bind, Pfizer, and More 04/05/13 Boston
Gilead Sciences Building on HIV, Becoming Cancer Drug Force 04/01/13 National
Adimab Grows Up, Looks to Pay Off the VCs In Unusual Way 02/22/13 Boston
Dyax, Adimab, Mersana, & More Boston Life Sciences Newsmakers 04/20/12 Boston
New England’s Emerging Biotech Stars: An Xconomy Forum In Pictures 04/09/12 Boston
See You Today at New England’s Emerging Biotech Stars***SOLD OUT*** 04/04/12 Boston
Adimab Obtains Series F Round 04/02/12 Boston
Page 1 of 3 next page »